Cargando…
PNS173 Impact of COVID-19 on HTA Bodies and Pharmaceutical Company Pricing and Market Access Activities
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631951/ http://dx.doi.org/10.1016/j.jval.2020.08.1617 |
| _version_ | 1784607662096252928 |
|---|---|
| author | Thomas, M. Craddy, P. Foxon, G. |
| author_facet | Thomas, M. Craddy, P. Foxon, G. |
| author_sort | Thomas, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8631951 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86319512021-12-01 PNS173 Impact of COVID-19 on HTA Bodies and Pharmaceutical Company Pricing and Market Access Activities Thomas, M. Craddy, P. Foxon, G. Value Health Article Published by Elsevier Inc. 2020-12 2020-12-11 /pmc/articles/PMC8631951/ http://dx.doi.org/10.1016/j.jval.2020.08.1617 Text en Copyright © 2020 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Thomas, M. Craddy, P. Foxon, G. PNS173 Impact of COVID-19 on HTA Bodies and Pharmaceutical Company Pricing and Market Access Activities |
| title | PNS173 Impact of COVID-19 on HTA Bodies and Pharmaceutical Company Pricing and Market Access Activities |
| title_full | PNS173 Impact of COVID-19 on HTA Bodies and Pharmaceutical Company Pricing and Market Access Activities |
| title_fullStr | PNS173 Impact of COVID-19 on HTA Bodies and Pharmaceutical Company Pricing and Market Access Activities |
| title_full_unstemmed | PNS173 Impact of COVID-19 on HTA Bodies and Pharmaceutical Company Pricing and Market Access Activities |
| title_short | PNS173 Impact of COVID-19 on HTA Bodies and Pharmaceutical Company Pricing and Market Access Activities |
| title_sort | pns173 impact of covid-19 on hta bodies and pharmaceutical company pricing and market access activities |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631951/ http://dx.doi.org/10.1016/j.jval.2020.08.1617 |
| work_keys_str_mv | AT thomasm pns173impactofcovid19onhtabodiesandpharmaceuticalcompanypricingandmarketaccessactivities AT craddyp pns173impactofcovid19onhtabodiesandpharmaceuticalcompanypricingandmarketaccessactivities AT foxong pns173impactofcovid19onhtabodiesandpharmaceuticalcompanypricingandmarketaccessactivities |